# Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma

> **NCT00349414** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 70 (estimated)

## Conditions studied

- Advanced Glaucoma
- Refractory Glaucoma

## Interventions

- **PROCEDURE:** Micropulse Transscleral Cyclophotocoagulation
- **PROCEDURE:** Conventional Transscleral Cyclophotocoagulation

## Key facts

- **NCT ID:** NCT00349414
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2008-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00349414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00349414, "Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00349414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*